Update on the Efficacy and Safety of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Chronic Diseases: A Systematic Review and Meta-Analysis.

Medicina (Kaunas) · 2025 · PMC11857657 · PMID 40005319

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

nearly statistically significantno p-value reported

The results indicated that SGLT2 inhibitors were associated with a nearly statistically significant 2% reduction in the risk of any adverse events compared to the placebo (RR = 0.98, 95% CI = 0.96–1.00, I 2 = 61%, Figure 3 a).

also in 84 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.